XML 58 R40.htm IDEA: XBRL DOCUMENT v2.4.0.8
PARENT-ONLY CONDENSED FINANCIAL INFORMATION (Tables)
12 Months Ended
Jun. 30, 2014
Condensed Financial Information of Parent Company Only Disclosure [Abstract]  
Schedule of Condensed Balance Sheet
BofI Holding, Inc.
CONDENSED BALANCE SHEETS
 
At June 30,
(Dollars in thousands)
2014
 
2013
ASSETS
 
 
 
Cash and cash equivalents
$
3,049

 
$
18,341

Loans
34

 
31

Investment securities
88

 
105

Other assets
4,184

 
1,770

Due from subsidiary
86

 
100

Investment in subsidiary
372,074

 
257,269

Total assets
$
379,515

 
$
277,616

LIABILITIES AND STOCKHOLDERS’ EQUITY
 
 
 
Junior subordinated debentures
$
5,155

 
$
5,155

Accrued interest payable
15

 
15

Accounts payable and accrued liabilities
3,567

 
4,184

Total liabilities
8,737

 
9,354

Stockholders’ equity
370,778

 
268,262

Total liabilities and stockholders' equity
$
379,515

 
$
277,616

Schedule of Condensed Income Statement
BofI Holding, Inc.
STATEMENTS OF INCOME
 
Year Ended June 30,
(Dollars in thousands)
2014
 
2013
 
2012
Interest income
$
82

 
$
130

 
$
93

Interest expense
143

 
151

 
149

Net interest (expense) income
(61
)
 
(21
)
 
(56
)
Provision for loan losses

 

 

Net interest (expense) income, after provision for loan losses
(61
)
 
(21
)
 
(56
)
Non-interest income (loss)
(3
)
 
(112
)
 
(71
)
Non-interest expense
3,218

 
2,532

 
2,185

Income (loss) before dividends from subsidiary and equity in undistributed income of subsidiary
(3,282
)
 
(2,665
)
 
(2,312
)
Dividends from subsidiary
2,600

 
1,300

 
2,600

Equity in undistributed earnings of subsidiary
56,638

 
41,656

 
29,120

Net income
$
55,956

 
$
40,291

 
$
29,408

Comprehensive income
$
56,390

 
$
34,926

 
$
25,012

Schedule of Condensed Cash Flow Statement
BofI Holding, Inc.
STATEMENT OF CASH FLOWS
 
Year Ended June 30,
(Dollars in thousands)
2014
 
2013
 
2012
CASH FLOWS FROM OPERATING ACTIVITIES:
 
 
 
 
 
Net income
$
55,956

 
$
40,291

 
$
29,408

Adjustments to reconcile net income to net cash used in operating activities:
 
 
 
 
 
Accretion of discounts on securities
(41
)
 
(70
)
 
(52
)
Impairment charge on securities
56

 
113

 
71

Accretion of discounts on loans
(12
)
 
(10
)
 
(9
)
Stock-based compensation expense
4,358

 
3,297

 
2,493

Tax effect from exercise of common stock options and vesting of restricted stock grants
(4,856
)
 
(2,332
)
 
(740
)
Equity in undistributed earnings of subsidiary
(72,296
)
 
(41,693
)
 
(29,113
)
Decrease (increase) in other assets
(2,400
)
 
(442
)
 
209

Increase (decrease) in other liabilities
(616
)
 
(8
)
 
(2,618
)
Net cash provided by (used in) operating activities
(19,851
)
 
(854
)
 
(351
)
CASH FLOWS FROM INVESTING ACTIVITIES:
 
 
 
 
 
Proceeds from principal repayments on loans
9

 
5

 
6

Investment in subsidiary
(42,073
)
 
(20,000
)
 
(22,000
)
Net cash used in investing activities
(42,064
)
 
(19,995
)
 
(21,994
)
CASH FLOWS FROM FINANCING ACTIVITIES:
 
 
 
 
 
Proceeds from issuance of convertible preferred stock—Series B & C

 
18,544

 
19,487

Proceeds from exercise of common stock options
500

 
260

 
726

Proceeds from issuance of common stock
41,576

 
6,765

 
13,345

Tax effect from exercise of common stock options and vesting of restricted stock grants
4,856

 
2,332

 
739

Cash dividends on preferred stock
(309
)
 
(1,137
)
 
(969
)
Net cash provided by (used in) financing activities
46,623

 
26,764

 
33,328

NET CHANGE IN CASH AND CASH EQUIVALENTS
(15,292
)
 
5,915

 
10,983

CASH AND CASH EQUIVALENTS—Beginning of year
18,341

 
12,426

 
1,443

CASH AND CASH EQUIVALENTS—End of year
$
3,049

 
$
18,341

 
$
12,426